To measure protective NAbs, COVID-19 convalescent plasma was diluted (1:10) and incubated with HRP-conjugated, recombinant SARS-CoV-2-S1 RBD for 30 min at 37 °C prior to adding to an ACE2 pre-coated ELISA plates. The gene discussed is ACE2; the disease is COVID-19.